Device: dextran sulfate adsorption (DrugBank: Dextran, Sulfate)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
79 | Homozygous familial hypercholesterolemia | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02286596 (ClinicalTrials.gov) | April 2013 | 3/11/2014 | Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia | Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia | Homozygous Familial Hypercholesterolemia | Device: heparin-induced extracorporeal LDL precipitation;Device: dextran sulfate adsorption | Laval University | NULL | Completed | 18 Years | 60 Years | Both | 9 | N/A | Canada |